FRANCE Trends and Developments Contributed by: Liliana Eskenazi, Julie Ernewein and Pauline Lecrenais, Fréget Glaser et Associés
Fréget Glaser et Associés 7 rue Royale 75008 Paris France Tel: +33 (0) 1 47 23 78 80 Email: contact@freget-glaser.fr Web: www.freget-glaser.fr
The deployment of artificial intelligence (AI) in health - care is driving major transformation in France. As innovation accelerates and legal frameworks evolve at both national and European levels, stakeholders must navigate a fast-changing, complex landscape. AI Deployment: A Strategic Challenge for France’s Healthcare Sector AI is being integrated into the French healthcare sys - tem across a wide range of applications: medical imaging, diagnostic tools, remote patient monitoring, drug discovery, and optimisation of operational and administrative processes. These technologies are at various stages of maturity. According to the AI Use Observatory of the French National Agency for the Performance of Health and Medico-Social Institutions (ANAP), around 50 AI-pow - ered solutions are already being used in hospitals and medico-social organisations. This dynamic was further reinforced in February 2025, when the Summit for Action on AI gathered research - ers, healthcare professionals, and entrepreneurs at PariSanté Campus to discuss concrete AI-driven solutions in the healthcare sector. On this occasion, the Minister of Health presented a report entitled “The State of AI in healthcare in France”, reaffirming the government’s aim to promote a sovereign, competi - tive, and trustworthy approach to AI in healthcare.
Key priorities set out in the report include: • accelerating innovation through a sustainable eco - nomic model; • supporting healthcare professionals with training and upskilling; • building a regulatory framework and best practices that foster trust and safety; and • adapting health technology assessments to the specific characteristics of AI. Strategic investments are also central to this national objective. France’s support of the development of innovations incorporating AI in healthcare forms part of the Digital Health Acceleration Strategy under the “France 2030” plan. The country has so far invested EUR500 million in digital health solutions, 50% of which is dedicated to projects involving AI. Major collaborative initiatives – such as PariSanté Campus and the Health Data Hub – bring together healthcare institutions, researchers, and industry lead - ers. Regulatory bodies such as the French National Agency for the Safety of Medicines and Health Prod - ucts (ANSM) and the French National Health Authority (HAS) play a crucial role in certifying and guiding AI implementation. The HAS recently issued a general guide for selecting digital medical devices, including AI systems. A more specific economic evaluation guide is expected soon.
83
CHAMBERS.COM
Powered by FlippingBook